12.54
price down icon24.05%   -3.97
after-market Dopo l'orario di chiusura: 12.70 0.16 +1.28%
loading
Precedente Chiudi:
$16.51
Aprire:
$16.5
Volume 24 ore:
5.32M
Relative Volume:
4.15
Capitalizzazione di mercato:
$1.40B
Reddito:
$577.74M
Utile/perdita netta:
$-149.78M
Rapporto P/E:
-8.9571
EPS:
-1.4
Flusso di cassa netto:
$-78.21M
1 W Prestazione:
-22.64%
1M Prestazione:
-26.24%
6M Prestazione:
-52.37%
1 anno Prestazione:
-33.26%
Intervallo 1D:
Value
$12.46
$16.51
Intervallo di 1 settimana:
Value
$12.46
$16.67
Portata 52W:
Value
$12.46
$34.13

Novocure Ltd Stock (NVCR) Company Profile

Name
Nome
Novocure Ltd
Name
Telefono
44 (0)15 3475 6700
Name
Indirizzo
NO. 4 THE FORUM, ST. HELIER
Name
Dipendente
1,488
Name
Cinguettio
@novocure
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
NVCR's Discussions on Twitter

Confronta NVCR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
NVCR
Novocure Ltd
12.54 1.82B 577.74M -149.78M -78.21M -1.40
Medical Devices icon
ABT
Abbott Laboratories
125.64 218.92B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.21 152.62B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
396.66 153.22B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.32 117.89B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
75.80 45.12B 5.54B 4.18B 623.10M 7.00

Novocure Ltd Stock (NVCR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-08 Iniziato Ladenburg Thalmann Buy
2024-12-02 Aggiornamento Evercore ISI In-line → Outperform
2024-10-16 Aggiornamento H.C. Wainwright Neutral → Buy
2023-11-20 Ripresa JP Morgan Neutral
2023-08-28 Downgrade H.C. Wainwright Buy → Neutral
2023-08-08 Aggiornamento Piper Sandler Neutral → Overweight
2023-08-04 Iniziato SVB Securities Outperform
2023-07-31 Aggiornamento Evercore ISI Underperform → In-line
2023-06-07 Aggiornamento Wedbush Underperform → Neutral
2023-05-16 Aggiornamento Wells Fargo Equal Weight → Overweight
2023-03-17 Downgrade JP Morgan Neutral → Underweight
2023-01-06 Downgrade Wells Fargo Overweight → Equal Weight
2023-01-05 Reiterato H.C. Wainwright Buy
2022-11-29 Aggiornamento Wells Fargo Equal Weight → Overweight
2022-10-24 Downgrade Piper Sandler Overweight → Neutral
2022-07-05 Downgrade Evercore ISI In-line → Underperform
2022-05-16 Iniziato H.C. Wainwright Buy
2022-02-08 Iniziato Loop Capital Buy
2022-02-02 Aggiornamento Oppenheimer Perform → Outperform
2022-01-20 Aggiornamento Truist Hold → Buy
2022-01-03 Aggiornamento Evercore ISI Underperform → In-line
2021-07-01 Downgrade Mizuho Buy → Neutral
2021-04-14 Downgrade Wedbush Neutral → Underperform
2021-01-25 Reiterato Piper Sandler Overweight
2020-09-23 Iniziato Northland Capital Outperform
2020-09-18 Downgrade Wells Fargo Overweight → Equal Weight
2020-09-17 Downgrade Truist Buy → Hold
2020-06-01 Ripresa Oppenheimer Perform
2020-05-01 Downgrade Oppenheimer Outperform → Perform
2020-04-09 Downgrade Evercore ISI In-line → Underperform
2020-03-05 Aggiornamento Wells Fargo Equal Weight → Overweight
2020-01-02 Downgrade Evercore ISI Outperform → In-line
2019-07-29 Aggiornamento SunTrust Hold → Buy
2019-07-26 Downgrade JP Morgan Overweight → Neutral
2019-07-26 Downgrade Wedbush Outperform → Neutral
2019-03-20 Iniziato SunTrust Hold
2018-11-02 Downgrade Wells Fargo Outperform → Market Perform
2018-07-16 Iniziato Evercore ISI Outperform
2018-04-18 Reiterato Mizuho Buy
2018-02-23 Reiterato Mizuho Buy
2017-05-24 Aggiornamento Wells Fargo Market Perform → Outperform
2016-07-29 Reiterato Wedbush Outperform
2016-01-19 Iniziato Barclays Underweight
2015-12-02 Iniziato Deutsche Bank Hold
Mostra tutto

Novocure Ltd Borsa (NVCR) Ultime notizie

pulisher
Jul 24, 2025

Novocure Beat Revenue Expectations As Patient Numbers Grew - Finimize

Jul 24, 2025
pulisher
Jul 24, 2025

NovoCure Limited Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

NovoCure Limited (NASDAQ:NVCR) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jul 24, 2025
pulisher
Jul 24, 2025

NovoCure Ltd (NVCR) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com

Jul 24, 2025
pulisher
Jul 24, 2025

Novocure stock hits 52-week low at 14.17 USD - Investing.com Australia

Jul 24, 2025
pulisher
Jul 24, 2025

Novocure Ltd reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

Novocure: Steady Ahead of Key Milestones - The Motley Fool

Jul 24, 2025
pulisher
Jul 24, 2025

NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Jul 24, 2025
pulisher
Jul 24, 2025

NovoCure Ltd Q2 2025 Earnings: EPS Loss of $0.36 Beats Estimates - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Novocure Ltd earnings beat by $0.02, revenue topped estimates - Investing.com South Africa

Jul 24, 2025
pulisher
Jul 24, 2025

NovoCure Ltd SEC 10-Q Report - TradingView

Jul 24, 2025
pulisher
Jul 24, 2025

Novocure Reports Second Quarter 2025 Financial Results - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about NovoCure Limited stockBreakthrough wealth creation - Autocar Professional

Jul 23, 2025
pulisher
Jul 20, 2025

What drives NovoCure Limited stock priceRobust investment performance - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

Is NovoCure Limited a good long term investmentUnmatched market gains - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

M&T Bank Corp Sells 1,750 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World

Jul 19, 2025
pulisher
Jul 16, 2025

How NovoCure Limited stock performs during market volatilityBreakout Level Watch - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes NovoCure Limited stock price move sharplyFree Stock Market Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why NovoCure Limited stock attracts strong analyst attentionFast Growing Stocks - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

NovoCure (NASDAQ:NVCR) shareholders are up 4.2% this past week, but still in the red over the last three years - simplywall.st

Jul 14, 2025
pulisher
Jul 14, 2025

Teacher Retirement System of Texas Buys 3,123 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Most Volatile Stocks in the US (July 2025) - Investing.com

Jul 14, 2025
pulisher
Jul 11, 2025

NovoCure Ltd Stock Price Falls 3.41% Amid Analyst Predictions of 81.88% Upside - AInvest

Jul 11, 2025
pulisher
Jul 10, 2025

LADENBURG THALM/SH SH Initiates Coverage on NovoCure (NASDAQ:NVCR) - Defense World

Jul 10, 2025
pulisher
Jul 08, 2025

NovoCure stock initiated with Buy rating at Ladenburg Thalmann By Investing.com - Investing.com South Africa

Jul 08, 2025
pulisher
Jul 08, 2025

This Circle Internet Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Jul 08, 2025
pulisher
Jul 08, 2025

NovoCure stock initiated with Buy rating at Ladenburg Thalmann - Investing.com

Jul 08, 2025
pulisher
Jul 03, 2025

NovoCure stock maintains Buy rating at H.C. Wainwright on positive cancer trial data - Investing.com Nigeria

Jul 03, 2025
pulisher
Jul 01, 2025

New Clinical Data: Revolutionary Cancer Therapy Cuts Pancreatic Cancer Pain by 47%, Delays Opioid Use - Stock Titan

Jul 01, 2025
pulisher
Jun 30, 2025

Novocure to Present Final Secondary Endpoint Data from the Phase - GuruFocus

Jun 30, 2025
pulisher
Jun 30, 2025

NVCR SEC FilingsNovocure 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 30, 2025
pulisher
Jun 30, 2025

Novocure to Report Second Quarter 2025 Financial Results | NVCR Stock News - GuruFocus

Jun 30, 2025
pulisher
Jun 29, 2025

NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jun 29, 2025
pulisher
Jun 27, 2025

Demystifying NovoCure: Insights From 4 Analyst Reviews - Nasdaq

Jun 27, 2025
pulisher
Jun 18, 2025

NovoCure Limited's (NASDAQ:NVCR) P/S Still Appears To Be Reasonable - simplywall.st

Jun 18, 2025
pulisher
Jun 16, 2025

Rhumbline Advisers Has $2.69 Million Stock Position in NovoCure Limited (NASDAQ:NVCR) - Defense World

Jun 16, 2025
pulisher
Jun 12, 2025

Novocure’s SWOT analysis: innovative cancer therapy firm faces growth hurdles By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Novocure’s SWOT analysis: innovative cancer therapy firm faces growth hurdles - Investing.com India

Jun 12, 2025
pulisher
Jun 06, 2025

NovoCure Ltd (NVCR) Shares Up 4.08% on Jun 6 - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial - TradingView

Jun 06, 2025
pulisher
Jun 06, 2025

Mackenzie Financial Corp Purchases Shares of 6,820 NovoCure Limited (NASDAQ:NVCR) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Insider Sell Alert: Frank Leonard Sells 30,196 Shares of NovoCure Ltd (NVCR) - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

Novocure at Jefferies Conference: Expanding Horizons in Cancer Treatment - Investing.com

Jun 04, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Has $682,000 Position in NovoCure Limited (NASDAQ:NVCR) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

H.C. Wainwright reiterates Buy rating on NovoCure stock after ASCO data - Investing.com Nigeria

Jun 02, 2025
pulisher
Jun 02, 2025

NovoCure Ltd (NVCR) Shares Down 7.43% on Jun 2 - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

NovoCure's Tumor Treating Fields Boost One-Year And Pain-Free Survival In Pancreatic Cancer Trial - Yahoo Finance

Jun 02, 2025
pulisher
Jun 02, 2025

Novocure (NVCR) Gains Support for Future Launch from Promising T - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Novocure (NVCR) Gains Support for Future Launch from Promising Trial Outcomes | NVCR Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

H.C. Wainwright reiterates Buy rating on NovoCure stock after ASCO data By Investing.com - Investing.com South Africa

Jun 02, 2025

Novocure Ltd Azioni (NVCR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$286.58
price down icon 0.03%
medical_devices STE
$227.25
price up icon 0.79%
medical_devices PHG
$25.84
price down icon 0.04%
$86.74
price up icon 0.36%
$76.77
price down icon 0.62%
medical_devices EW
$75.80
price down icon 1.44%
Capitalizzazione:     |  Volume (24 ore):